spotbot ii microarray printer (Arrayit Corporation)
90
Structured Review
Arrayit Corporation
spotbot ii microarray printer
Spotbot Ii Microarray Printer, supplied by Arrayit Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spotbot+ii/spotbot+3+microarrayer/pmc10102909-94-26-30
Average 90 stars, based on 1 article reviews
Spotbot Ii Microarray Printer, supplied by Arrayit Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spotbot+ii/spotbot+3+microarrayer/pmc10102909-94-26-30
Average 90 stars, based on 1 article reviews
spotbot ii microarray printer - by Bioz Stars,
2026-09
90/100 stars
Images
1) Product Images from "Development of a biomarker signature using grating-coupled fluorescence plasmonic microarray for diagnosis of MIS-C"
Article Title: Development of a biomarker signature using grating-coupled fluorescence plasmonic microarray for diagnosis of MIS-C
Journal: Frontiers in Bioengineering and Biotechnology
doi: 10.3389/fbioe.2023.1066391
Figure Legend Snippet: Comparison of USA vs. Colombia MIS-C patient samples by GCFP microarray. (A) Heat map of A2 serum samples comparing USA to Colombia samples. The USA patient population has a more robust signature. (B) Heat of A2 saliva samples comparing USA to Colombia samples, USA has a more robust signature.
Techniques Used: Comparison, Microarray
Figure Legend Snippet: Serum from Cohorts and individual patient comparison of GCFP microarray assay to MIA. To compare a traditional MIA with the GCFP microarray, 11 analytes were included in both assays. (A) A heat map was generated by log transforming GCFP detection ratios and using the mean of each analyte detection ratio for each cohort. Of the 11 analytes, 5 were below the detection limit of the GCFP first generation biosensor chip. (B) A heat map generated by log transforming GCFP detection ratios from individual serum samples from cohort A1. (C) A heat map generated by log transforming GCFP detection ratios from individual serum samples from cohort A2. (D) A heat map generated by log transforming GCFP detection ratios from individual serum samples from cohort B1. (E) A heat map generated by log transforming GCFP detection ratios from individual serum samples from cohort B2. (F) A heat map generated by log transforming GCFP detection ratios from individual serum samples from cohort B3. 16 of the 44 shared serum samples had similar biomarker signatures, while IL-4, IL-6 and CCL20 were not consistently detected on the GCFP chip.
Techniques Used: Comparison, Microarray, Generated, Biomarker Discovery
Related Articles
Marker:Article Title: Grating coupled SPR microarray analysis of proteins and cells in blood from mice with breast cancer. Article Snippet: Biomarker discovery for early disease diagnosis is highly important.. Of late, much effort has been made to analyze complex biological fluids in an effort to develop new markers specific for different cancer types.. Recent advancements in label-free technologies such as surface plasmon resonance (SPR)-based biosensors have shown promise as a diagnostic tool since there is no need for labeling or separation of cells. Concentration Assay:Article Title: Grating coupled SPR microarray analysis of proteins and cells in blood from mice with breast cancer. Article Snippet: Biomarker discovery for early disease diagnosis is highly important.. Of late, much effort has been made to analyze complex biological fluids in an effort to develop new markers specific for different cancer types.. Recent advancements in label-free technologies such as surface plasmon resonance (SPR)-based biosensors have shown promise as a diagnostic tool since there is no need for labeling or separation of cells. Microarray:Article Title: Grating coupled SPR microarray analysis of proteins and cells in blood from mice with breast cancer. Article Snippet: Biomarker discovery for early disease diagnosis is highly important.. Of late, much effort has been made to analyze complex biological fluids in an effort to develop new markers specific for different cancer types.. Recent advancements in label-free technologies such as surface plasmon resonance (SPR)-based biosensors have shown promise as a diagnostic tool since there is no need for labeling or separation of cells. |